Allergy Immunotherapy: Shots, Tablets and Drops

Treatment Guide

Allergen immunotherapy uses repeated exposure to carefully selected allergens to reduce sensitivity over time. The main inhalant-allergy routes are injections and under-the-tongue treatment, each with different evidence, safety steps, schedules, and practical demands.

Request an appointment Find a clinic

Allergy Immunotherapy: Shots, Tablets and Drops | Modena Health

Understanding Allergy Immunotherapy

Allergy Immunotherapy: what the first evaluation should clarify

Shots versus sublingual treatment

Subcutaneous immunotherapy uses injections in a clinical setting. Sublingual immunotherapy uses tablets or drops under the tongue, with products and regulatory status varying by allergen. The best route depends on allergens, age, asthma control, schedule, and preference.

Build-up, maintenance, and results

Treatment begins with lower doses and progresses to maintenance according to the protocol. Benefit develops gradually, and a multi-year course is commonly discussed. Missed doses, illness, and reactions may require schedule changes.

Review allergy injections information to compare goals, eligibility, practical steps, safety, and follow-up with a clinician.

Review slit allergy information to compare goals, eligibility, practical steps, safety, and follow-up with a clinician.

Modena Health physician speaking with a patient in an exam room.

Care Options

Safety and candidacy

Uncontrolled asthma and certain medical or medication factors can increase risk. Patients need a clear reaction plan and must follow post-dose observation or activity instructions. Immunotherapy is not started from test results alone.

Allergy Shots vs. Sublingual Immunotherapy

The comparison starts with clinically relevant allergy and the exact treatment being considered. Convenience alone cannot establish the most suitable option. ACAAI distinguishes injection and sublingual approaches, and FDA lists specific approved sublingual tablets.

Discussion point	Allergy shots	Sublingual tablets	Allergy drops
Form	Injections under a clinical program	A named allergen extract tablet	A liquid sublingual formulation
Product discussion	Relevant allergens and program requirements	The exact product and its current labeling	Formulation, evidence and off-label use
U.S. regulatory distinction	Separate from sublingual tablet approval	Specific FDA-approved products	Not FDA-approved as sublingual allergy drops
Supervision	The team explains clinic visits and observation	The team explains product-specific training and follow-up	The prescriber explains the proposed supervision and limitations
Insurance	Plan and service requirements need confirmation	Plan and product requirements need confirmation	Coverage must be checked for the exact proposed service

Is one format best for everyone?

No. The specialist assesses the individual history, relevant allergens, evidence and practical requirements. This table does not choose treatment.

Can I switch between them using an online comparison?

A change belongs with the treating clinician. The allergy shots page explains injection care, and the SLIT page explains sublingual care. The drops and tablets article focuses on terminology and regulatory questions.

Know the Next Step

Safety on injection days

Local swelling is common. Systemic reactions can involve hives, swelling, breathing, gastrointestinal, or circulation symptoms and require prompt treatment. Report symptoms before leaving and follow the required observation period.

Tell staff about asthma symptoms, fever, new medicines, pregnancy, a prior delayed reaction, or an unusually long gap between injections before the dose is given. Follow clinic instructions about strenuous exercise around treatment.

Care Connected with Allergy Immunotherapy

Evaluation and treatment related to Allergy Immunotherapy

These diagnostic and treatment topics can shape a focused allergy immunotherapy discussion.

Allergy Shots (Subcutaneous Immunotherapy)

Allergy Shots (Subcutaneous Immunotherapy) can clarify a separate question that often appears while evaluating Allergy Immunotherapy.

View guide

Sublingual Immunotherapy (SLIT)

Use the Sublingual Immunotherapy (SLIT) guide to compare preparation, evidence, and next steps alongside Allergy Immunotherapy.

View guide

Environmental Allergy Testing and Evaluation

Open Environmental Allergy Testing and Evaluation for connected testing or treatment decisions that may follow a Allergy Immunotherapy discussion.

View guide

Patient guide

Allergy Immunotherapy: decisions, preparation, and safety

Quick answer

Allergy immunotherapy is a disease-modifying treatment for selected patients with clinically relevant inhalant or venom allergy. It differs from symptom medicines and from food oral immunotherapy.

Who may want to ask about it

It may be discussed when allergic rhinitis, eye allergy, or selected allergic asthma remains burdensome despite appropriate exposure reduction and medicine, when side effects or access limit usual care, or when a patient prefers an immunomodulating option.

What the visit or test may answer

The allergist matches the symptom season and exposure pattern with focused skin or blood testing, reviews asthma control and other risk factors, and identifies only the allergens that belong in the treatment decision.

How to prepare

Bring prior test reports, a symptom calendar, medication response, asthma and reaction history, work or home exposures, travel schedule, insurance information, and questions about clinic visits or daily home treatment.

Limits and safety

Immunotherapy does not provide immediate relief, does not treat every positive test, and cannot guarantee permanent symptom freedom. Adherence and a safe response plan matter for both injections and sublingual products.

When symptoms need urgent care

A systemic reaction after immunotherapy can be serious. Follow the written treatment and emergency instructions and seek immediate care for breathing trouble, throat swelling, faintness, or rapidly progressive multisystem symptoms.

Alternatives to discuss

Alternatives may include more focused exposure reduction, improved nasal or asthma medicine technique, another medicine plan, a different immunotherapy route, or continued symptom management without immunotherapy.

A useful next step

Ask which allergens are clinically relevant, why shots or a specific sublingual product is proposed, what the time commitment is, how safety is handled, and what improvement will be reviewed after a defined period.

Treat Relevant Allergy

Who may benefit from allergen immunotherapy?

Current guidance supports offering or referring for inhalant immunotherapy when allergic rhinitis, with or without allergic asthma, is inadequately controlled with medical therapy and exposure reduction or when a patient prefers immunomodulation. Testing must confirm sensitization, but the selected allergen must also match actual symptoms and meaningful exposure.

Immunotherapy is not started simply because a panel has many positives. The clinician reviews when and where symptoms occur, whether asthma is controlled, prior reactions, pregnancy status, medicines, ability to use epinephrine, and whether the patient can follow the clinic or home schedule. Children, adults, seasonal symptoms, and year-round exposures can require different practical plans.

Compare the Routes

Allergy shots, FDA-approved tablets, and custom drops

Subcutaneous immunotherapy, or SCIT, uses injections in a medical setting with scheduled observation. Sublingual immunotherapy, or SLIT, is placed under the tongue. In the United States, FDA-approved tablets are available for specific grass, ragweed, and dust-mite allergies. Customized liquid allergy drops have a different evidence, dosing, regulatory, and insurance context.

The routes are not interchangeable by volume or allergen list. The clinician compares the relevant allergens, product evidence, asthma status, age, dosing consistency, clinic access, home safety, cost, and preference. A patient should know the exact proposed product or formulation rather than accepting the broad label “immunotherapy.”

Plan for Time

Build-up, maintenance, and expected duration

SCIT generally includes a build-up phase with increasing doses followed by maintenance. SLIT tablets use product-specific start dates and daily schedules; seasonal products may begin before the expected pollen season. Missed doses, reactions, illness, asthma symptoms, pregnancy, travel, or a long interruption can change what happens next.

Improvement is gradual. For patients with good symptom control from inhalant immunotherapy, the 2024 clinical practice guideline recommends a minimum treatment duration of three years, with longer duration based on response and shared decision-making. This does not mean every patient stops at the same date or receives the same schedule.

Measure Real Benefit

How to know whether immunotherapy is working

Track the outcomes that led to treatment: symptom days, sleep, activity, seasonal flares, medicine use, asthma attacks, missed work or school, and quality of life. Repeat allergy testing is generally not used to prove that ongoing immunotherapy works unless exposure changes or symptom control is lost.

At follow-up, the clinician reviews dose progress, adherence, reactions, competing diagnoses, new exposures, and whether the selected allergens still match the problem. If benefit is unclear, the next decision may involve more time, a schedule or formulation review, another diagnosis, or stopping after a careful discussion.

Separate Similar-Sounding Treatments

Inhalant immunotherapy, venom therapy, and food OIT

Inhalant immunotherapy treats allergies such as pollens, dust mites, or other selected aeroallergens. Venom immunotherapy is a specialized injection pathway for patients with an appropriate stinging-insect allergy history. Food OIT is a different treatment that uses a confirmed food allergen to raise the reaction threshold while dosing continues.

All three involve allergen exposure, but their goals, doses, products, evidence, and emergency procedures differ. A patient searching for “allergy desensitization” should first identify whether the concern is inhalant exposure, a sting, or a food before comparing programs.

Compare the Options

SCIT and SLIT questions to compare

The best route is the evidence-based option that matches the relevant allergen and can be followed safely.

SCIT and SLIT questions to compare
Decision point	Allergy shots (SCIT)	Sublingual treatment (SLIT)
Where treatment occurs	Injections and observation in a medical setting	First-dose plan and product-specific follow-up; later doses commonly at home
Allergen coverage	Selected clinically relevant allergens in the prescribed injection program	Specific FDA-approved tablet allergens or a separately discussed custom liquid formulation
Routine	Build-up and maintenance clinic schedule	Consistent under-the-tongue dosing according to the exact product plan
Common burden	Travel, visit time, injections, and post-dose observation	Daily adherence, oral symptoms, home safety, and refill continuity
Regulatory question	Licensed allergenic extracts used in a prescribed SCIT program	Named tablets have FDA labeling; custom liquid drops are not FDA-approved as allergy drops

Patient questions

Frequently asked questions about Allergy Immunotherapy

What is allergen immunotherapy?

It is repeated treatment with selected allergens intended to reduce sensitivity and symptoms over time. Common inhalant routes are allergy shots and under-the-tongue therapy.

Who is a candidate for allergy immunotherapy?

Candidates have a clinically relevant allergy confirmed by history and testing, ongoing burden or a preference for immunomodulation, and a safety profile that supports the chosen route.

Is immunotherapy the same as allergy medicine?

No. Antihistamines, nasal sprays, eye drops, and asthma medicines control symptoms or inflammation. Immunotherapy aims to modify the response to selected allergens over time.

How long does allergy immunotherapy take?

Benefit develops gradually. For patients benefiting from inhalant immunotherapy, current guidance recommends at least three years, with the total duration individualized by response and risk.

Can immunotherapy treat food allergy?

Traditional inhalant allergy shots and SLIT tablets are not food-allergy treatment. Food oral immunotherapy is a separate program with different dosing and safety requirements.

Can I start immunotherapy during pregnancy?

Current guidance recommends not initiating allergen immunotherapy during pregnancy. Decisions about an established maintenance program require the treating clinician’s individualized review.

Why does asthma control matter?

Uncontrolled asthma increases the risk of severe reactions. The clinician assesses asthma before starting and before subsequent treatment when symptoms suggest poor control.

Do local reactions mean treatment must stop?

Local reactions are common and do not automatically mean treatment ends. The clinical team reviews the pattern and decides whether any change is needed.

Will repeat allergy tests show whether immunotherapy works?

Usually not. Current guidance discourages repeat testing solely to measure efficacy unless exposure changes or symptoms lose control. Clinical outcomes are more useful.

Plan the next allergy immunotherapy conversation

Bring the symptom, reaction, testing, and treatment records named in this Allergy Immunotherapy guide so the visit can answer a focused question.

Request an appointment Find a clinic

Appointments & Insurance

Scheduling made easy for your experience.

We work with many major insurance carriers.

Don’t see your carrier?

Insurance participation varies by plan, provider, network, and location. Please contact our team with your insurance card to confirm current participation. View participating plans.